Control of Peripheral Nerve Myelination by the ß-Secretase BACE1

Cited by (726)

Items 201–300 of 726

1. Deficiency of Aph1B/C-γ-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment
   Tim Dejaegere, Lutgarde Serneels, Martin Schäfer, Jérôme Van Biervliet, Katrien Horré, Candan Depboylu, Daniel Alvarez‐Fischer, An Herreman, Michael Willem, Christian Haass et al. · 2008 · Proceedings of the National Academy of Sciences
2. Reduced BACE1 Activity Enhances Clearance of Myelin Debris and Regeneration of Axons in the Injured Peripheral Nervous System
   Mohamed H. Farah, Baohan Pan, Paul N. Hoffman, Dana V. Ferraris, Takashi Tsukamoto, Thien Nguyen, Philip C. Wong, Donald L. Price, Barbara Stauch Slusher, John Wesley Griffin · 2011 · Journal of Neuroscience
3. Lessons from a BACE1 inhibitor trial: Off‐site but not off base
   Debomoy K. Lahiri, Bryan Maloney, Justin M. Long, Nigel H. Greig · 2014 · Alzheimer s & Dementia
4. Potential Therapeutic Strategies for Alzheimer’s Disease Targeting or Beyondβ-Amyloid: Insights from Clinical Trials
   Qiutian Jia, Yulin Deng, Hong Qing · 2014 · BioMed Research International
5. The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer’s Disease
   Marcus O.W. Grimm, Valerie C. Zimmer, Johannes Lehmann, Heike S. Grimm, Tobias Hartmann · 2013 · BioMed Research International
6. Understanding BACE1: essential protease for amyloid-β production in Alzheimer’s disease
   John H. Stockley, Cora O’Neill · 2008 · Cellular and Molecular Life Sciences
7. Neuregulin1 displayed on motor axons regulates terminal Schwann cell-mediated synapse elimination at developing neuromuscular junctions
   Young Il Lee, Yue Li, Michelle Mikesh, Ian Smith, Klaus‐Armin Nave, Markus H. Schwab, Wesley J. Thompson · 2016 · Proceedings of the National Academy of Sciences
8. Novel Role of RanBP9 in BACE1 Processing of Amyloid Precursor Protein and Amyloid β Peptide Generation
   Madepalli Krishnappa Lakshmana, Il‐Sang Yoon, Eunice Chen, Elizabetta Bianchi, Edward H. Koo, David E. Kang · 2009 · Journal of Biological Chemistry
9. Prolonged Sox4 Expression in Oligodendrocytes Interferes with Normal Myelination in the Central Nervous System
   Michaela R. Potzner, Carola Griffel, Elke Lütjen-Drecoll, Michael R. Bösl, Michael Wegner, Elisabeth Sock · 2007 · Molecular and Cellular Biology
10. Identification and biology of β‐secretase
    Patty C. Kandalepas, Robert J. Vassar · 2011 · Journal of Neurochemistry
11. Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)
    Gary D. Probst, Ying‐zi Xu · 2012 · Expert Opinion on Therapeutic Patents
12. Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs
    Lozupone, Madia, Solfrizzi, Vincenzo, D’Urso, Francesca, Di Gioia, Ilaria, Sardone, Rodolfo, Dibello, Vittorio, Stallone, Roberta, Liguori, Angelo, Ciritella, Chiara, Daniele, Antonio et al. · 2020 · Expert Opinion on Emerging Drugs
13. The physical approximation of APP and BACE‐1: A key event in alzheimer's disease pathogenesis
    Jichao Sun, Subhojit Roy · 2017 · Developmental Neurobiology
14. Prostaglandin D2 synthase/GPR44: a signaling axis in PNS myelination
    Amelia Trimarco, Maria Grazia Forese, Valentina Alfieri, Alessandra Lucente, Paola Brambilla, Giorgia Dina, Damiana Pieragostino, Paolo Sacchetta, Yoshihiro Urade, Brigitte Boizet‐Bonhoure et al. · 2014 · Nature Neuroscience
15. Mice Deficient for the Type II Transmembrane Serine Protease, TMPRSS1/hepsin, Exhibit Profound Hearing Loss
    Michel Guipponi, Justin Tan, Ping Cannon, Lauren Donley, Pauline E. Crewther, Maria T. Clarke, Qingyu Wu, Robert K. Shepherd, Hamish S. Scott · 2007 · American Journal Of Pathology
16. β-Secretase: its biology as a therapeutic target in diseases
    Wang, Haibo, Li, Rena, Shen, Yong · 2013 · Trends in Pharmacological Sciences
17. Cell biology, regulation and inhibition of β‐secretase (BACE‐1)
    Clare E. Hunt, Anthony J. Turner · 2009 · FEBS Journal
18. Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
    Andrea M. Zuhl, Charles E. Nolan, Michael A. Brodney, Sherry Niessen, Kevin P. Atchison, Christopher D. Houle, David A. Karanian, Claude Ambroise, Jeffrey W. Brulet, Elizabeth M. Beck et al. · 2016 · Nature Communications
19. BACE1 Dependent Neuregulin Processing: Review
    Daniel Fleck, Alistair N. Garratt, Christian Haass, Michael Willem · 2012 · Current Alzheimer Research
20. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer’s disease
    Robert J. Andrew, Celia G. Fernandez, Molly Stanley, Hong Jiang, Phuong Anh H. Nguyen, Richard C. Rice, Virginie Buggia-Prévot, Pierre De Rossi, Kulandaivelu S. Vetrivel, Raza Lamb et al. · 2017 · Proceedings of the National Academy of Sciences
21. Inhibition of BACE1 for therapeutic use in Alzheimer's disease.
    Xiaoyang Luo, Riqiang Yan · 2010 · Europe PMC (PubMed Central)
22. Dysregulation of the neuregulin‐1– E rb B network modulates endogenous oligodendrocyte differentiation and preservation after spinal cord injury
    Marie‐Krystel Gauthier, Kamilla Kosciuczyk, Laura Tapley, Soheila Karimi‐Abdolrezaee · 2013 · European Journal of Neuroscience
23. Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer’s disease
    Riqiang Yan, Qingyuan Fan, John Zhou, Robert J. Vassar · 2016 · Neuroscience & Biobehavioral Reviews
24. BACE2 distribution in major brain cell types and identification of novel substrates
    Iryna Voytyuk, Stephan A. Müller, Julia Herber, An Snellinx, Dieder Moechars, Geert Loo, Stefan F. Lichtenthaler, Bart De Strooper · 2018 · Life Science Alliance
25. 2,2′,4′‐Trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice
    Zhiyuan Zhu, Chenjing Li, Xu Wang, Zhengyi Yang, Jing Chen, Lihong Hu, Hualiang Jiang, Xu Shen · 2010 · Journal of Neurochemistry
26. Schwann cells–axon interaction in myelination
    Carla Taveggia · 2016 · Current Opinion in Neurobiology
27. Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice
    Derya R. Shimshek, Laura H. Jacobson, Carine Kolly, Natasa Zamurovic, Kamal Kumar Balavenkatraman, Laurent Morawiec, Robert Kreutzer, Juliane Schelle, Mathias Jucker, Barbara Bertschi et al. · 2016 · Scientific Reports
28. Modulation of γ- and β-secretases as early prevention against Alzheimer's disease
    Voytyuk, Iryna, De Strooper, Bart, Chávez-Gutiérrez, Lucía · 2018 · Biological Psychiatry
29. Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes
    Frauke van Bebber, Alexander Hruscha, Michael Willem, Bettina Schmid, Christian Haass · 2013 · Journal of Neurochemistry
30. Beyond Wrapping: Canonical and Noncanonical Functions of Schwann Cells
    Carla Taveggia, M. Laura Feltri · 2022 · Annual Review of Neuroscience
31. Focal cerebral ischemia in rats alters APP processing and expression of Aβ peptide degrading enzymes in the thalamus
    Mikko O. Hiltunen, Petra M. Mäkinen, Sirpa Peräniemi, Juhani Sivenius, Thomas van Groen, Hilkka S. Soininen, Jukka Jolkkonen · 2009 · Neurobiology of Disease
32. A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses Aβ-induced biomarker abnormality on cultured fibroblasts
    Tapan K. Khan, Thomas J. Nelson, Vishal A. Verma, Paul A. Wender, Daniel L. Alkon · 2009 · Neurobiology of Disease
33. Antagonistic Effects of BACE1 and APH1B-γ-Secretase Control Axonal Guidance by Regulating Growth Cone Collapse
    Barão, Soraia, Gärtner, Annette, Leyva-Díaz, Eduardo, Demyanenko, Galina, Munck, Sebastian, Vanhoutvin, Tine, Zhou, Lujia, Schachner, Melitta, López-Bendito, Guillermina, Maness, Patricia F. et al. · 2015 · Cell Reports
34. Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways
    Christopher Böhm, F. Chen, Jean Sévalle, Seema Qamar, Roger B. Dodd, Y. Li, Gerold Schmitt‐Ulms, Paul E. Fraser, Peter St George‐Hyslop · 2015 · Molecular and Cellular Neuroscience
35. Dysregulation of intracellular trafficking and endosomal sorting in Alzheimer's disease: controversies and unanswered questions
    Toh, Wei Hong, Gleeson, Paul A. · 2016 · Biochemical Journal
36. Knock-In of Human BACE1 Cleaves Murine APP and Reiterates Alzheimer-like Phenotypes
    K. Pluci ska, Barry Crouch, David J. Koss, L. Robinson, Michael Siebrecht, Gernot Riedel, Bettina Platt · 2014 · Journal of Neuroscience
37. BACE2 Expression Increases in Human Neurodegenerative Disease
    Christopher J. Holler, Robin L. Webb, Ashley L. Laux, Tina L. Beckett, Dana M. Niedowicz, Rachel R. Ahmed, Yinxing Liu, Christopher R Simmons, Amy L.S. Dowling, Angela Spinelli et al. · 2011 · American Journal Of Pathology
38. Neuregulin 1 Role in Schwann Cell Regulation and Potential Applications to Promote Peripheral Nerve Regeneration
    Giovanna Gambarotta, Federica Fregnan, Sara Gnavi, Isabelle Perroteau · 2013 · International review of neurobiology
39. Targets for AD treatment: conflicting messages from γ-secretase inhibitors
    Kumar Sambamurti, Nigel H. Greig, Tadanobu Utsuki, Eliza Barnwell, Ekta Sharma, Cheryl Mazell, Narayan R. Bhat, Mark S. Kindy, Debomoy K. Lahiri, Miguel A. Pappolla · 2011 · Journal of Neurochemistry
40. Vimentin regulates peripheral nerve myelination
    Daniela Triolo, Giorgia Dina, Carla Taveggia, Ilaria Vaccari, Emanuela Porrello, Cristina Rivellini, Teuta Domi, Rosa La Marca, Federica Cerri, Alessandra Bolino et al. · 2012 · Development
41. Irreversible changes occurring in long-term denervated Schwann cells affect delayed nerve repair
    Giulia Ronchi, Michele Cillino, Giovanna Gambarotta, Benedetta Elena Fornasari, Stefania Raimondo, Pierfrancesco Pugliese, Pierluigi Tos, Adriana Cordova, Francesco Moschella, Stefano Geuna · 2017 · Journal of neurosurgery
42. Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
    Mattsson, N, Axelsson, M, Haghighi, S, Malmeström, C, Wu, G, Anckarsäter, R, Sankaranarayanan, S, Andreasson, U, Fredrikson, S, Gundersen, A et al. · 2009 · Multiple Sclerosis Journal
43. Modeling Alzheimer’s disease: from past to future
    Claudia Saraceno, Stefano Musardo, Elena E. Marcello, Silvia Pelucchi, Mónica Di Luca · 2013 · Frontiers in Pharmacology
44. BACE1 as a Therapeutic Target in Alzheimer’s Disease: Rationale and Current Status
    Genevieve M. Evin, Christopher Hince · 2013 · Drugs & Aging
45. Complex translational regulation of BACE1 involves upstream AUGs and stimulatory elements within the 5' untranslated region
    Marija Mihailovich, Rolf Thermann, Fabio Grohovaz, Matthias W. Hentze, Daniele Zacchetti · 2007 · Nucleic Acids Research
46. Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?
    Gumpeny Ramachandra Sridhar, Hanuman Thota, Appa Rao Allam, Changalasetty Suresh Babu, Siva Prasad Akula, C. Divakar · 2006 · Lipids in Health and Disease
47. Carbon nanomaterials and amyloid-beta interactions: potentials for the detection and treatment of Alzheimer's disease?
    Mohammad Mohajeri, Behzad Behnam, George Emilio Barreto, Amirhossein Sahebkar · 2019 · Pharmacological Research
48. Cdk5 Protein Inhibition and Aβ42 Increase BACE1 Protein Level in Primary Neurons by a Post-transcriptional Mechanism
    Katherine R. Sadleir, Robert J. Vassar · 2012 · Journal of Biological Chemistry
49. Novel Huprine Derivatives with Inhibitory Activity toward β‐Amyloid Aggregation and Formation as Disease‐Modifying Anti‐Alzheimer Drug Candidates
    Elisabet Viayna, Tània Gómez, Carles Galdeano, Lorena Ramírez, Míriam Ratia, Albert Badı́a, M. Victòria Clos, Ester Verdaguer, Fèlix Junyent, Antoni Camins et al. · 2010 · ChemMedChem
50. Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease
    Polina A. Egorova, Попугаева Елена Александровна, Безпрозванный Илья Борисович · 2015 · Seminars in Cell and Developmental Biology
51. Substrate ectodomain is critical for substrate preference and inhibition of γ-secretase
    Satoru Funamoto, Toru Sasaki, Seiko Ishihara, Mika Nobuhara, Masaki Nakano, Miho Watanabe‐Takahashi, Takashi Saito, Nobuto Kakuda, Tomohiro Miyasaka, Kiyotaka Nishikawa et al. · 2013 · Nature Communications
52. Consequences of Inhibiting Amyloid Precursor Protein Processing Enzymes on Synaptic Function and Plasticity
    Hui Wang, Andrea Megill, Kaiwen He, Alfredo Kirkwood, Hey‐Kyoung Lee · 2012 · Neural Plasticity
53. The molecular link between β- and γ-secretase activity on the amyloid β precursor protein
    Massimo Tabaton, Elena Tamagno · 2007 · Cellular and Molecular Life Sciences
54. Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties
    Olga G. Tatarnikova, М. А. Орлов, Natalia V. Bobkova · 2015 · Biochemistry (Moscow)
55. Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients
    Francesco Panza, Davide Seripa, Vincenzo Solfrizzi, Bruno Pietro Imbimbo, Madia Lozupone, Antonio Leo, Rodolfo Sardone, Gaetano Gagliardi, Lucia Lofano, Bianca C. Creanza et al. · 2016 · Expert Opinion on Emerging Drugs
56. Neuregulin-1 signalling and antipsychotic treatment
    Chao Deng, Bo Pan, Martin Engel, Xu‐Feng Huang · 2013 · Psychopharmacology
57. Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors
    Jared N. Cumming, Thuy X. Le, Sethu Kailasam Geetha Babu, Carolyn DiIanni Carroll, X. Chen, Leonard V. Favreau, Paul M. Gaspari, Tao Guo, Denmark Hobbs, Ying Huang et al. · 2008 · Bioorganic & Medicinal Chemistry Letters
58. Neuregulin/ErbB Signaling in Developmental Myelin Formation and Nerve Repair
    Carmen Birchmeier, David Bennett · 2016 · Current topics in developmental biology/Current Topics in Developmental Biology
59. Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation.
    Mihirbaran Mandal, Zhao-Ning Zhu, J. Cumming, Xiao-Xiang Liu, C. Strickland, R. Mazzola, J. Caldwell, P. Leach, M. Grzelak, L. Hyde et al. · 2012 · Journal of Medicinal Chemistry
60. Expression of ErbB4 in the neurons of Alzheimer's disease brain and APP/PS1 mice, a model of Alzheimer's disease
    Ran‐Sook Woo, Ji-Hye Lee, Ha-Nul Yu, Dae‐Yong Song, Tai‐Kyoung Baik · 2011 · Anatomy & Cell Biology
61. β-Galactoside α2,6-Sialyltransferase I Cleavage by BACE1 Enhances the Sialylation of Soluble Glycoproteins
    Ichiro Sugimoto, Satoshi Futakawa, Ritsuko Oka, Kazuko Ogawa, Jamey D. Marth, Eiji Miyoshi, Naoyuki Taniguchi, Yasuhiro Hashimoto, Shinobu Kitazume · 2007 · Journal of Biological Chemistry
62. Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging
    Jordi A. Matías‐Guiu, Celia Oreja‐Guevara, María Nieves Cabrera‐Martín, Teresa Moreno‐Ramos, José Luis Carreras, Jorge Matías‐Guiu · 2016 · Frontiers in Neurology
63. The Neuregulin1/ErbB system is selectively regulated during peripheral nerve degeneration and regeneration
    Giulia Ronchi, Kirsten Haastert‐Talini, Benedetta Elena Fornasari, Isabelle Perroteau, Stefano Geuna, Giovanna Gambarotta · 2015 · European Journal of Neuroscience
64. Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors
    Daniel F. Wyss, Yu‐Sen Wang, Hugh L. Eaton, Corey Strickland, Johannes H. Voigt, Zhaoning Zhu, Andrew W. Stamford · 2011 · Topics in current chemistry
65. Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System
    Kathryn M. Munro, Amelia Nash, Martina Pigoni, Stefan F. Lichtenthaler, Jenny Margaret Gunnersen · 2016 · Journal of Molecular Neuroscience
66. Niacin‐mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination
    Alessandra Bolino, Françoise Piguet, Valeria Alberizzi, Marta Pellegatta, Cristina Rivellini, Marta Guerrero‐Valero, Roberta Noseda, Chiara Brombin, Alessandro Nonis, Patrizia D’Adamo et al. · 2016 · EMBO Molecular Medicine
67. AP‐2 reduces amyloidogenesis by promoting BACE1 trafficking and degradation in neurons
    Sujoy Bera, Santiago Camblor‐Perujo, Elena Calleja Barca, Albert Negrete‐Hurtado, Julia Racho, Elodie De Bruyckere, Christoph Wittich, Nina Ellrich, Soraia Martins, James Adjaye et al. · 2020 · EMBO Reports
68. BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus
    Kang, Eugene L., Biscaro, Barbara, Piazza, Fabrizio, Tesco, Giuseppina · 2012 · Journal of Biological Chemistry
69. The Normal and Pathologic Roles of the Alzheimer's β-secretase, BACE1
    Patty C. Kandalepas, Robert J. Vassar · 2014 · Current Alzheimer Research
70. Phenserine
    Jochen Klein · 2007 · Expert Opinion on Investigational Drugs
71. Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
    Young-Ju Jang, Seong-Jun Kang, Hyun Su Park, Donghyun Lee, Jae Hoon Kim, Ju-El Kim, Dong‐Ik Kim, Chan‐Hwa Chung, Jeong‐Kee Yoon, Suk Ho Bhang · 2025 · Journal of Nanobiotechnology
72. The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders.
    E. Koutsilieri, A. Rethwilm, C. Scheller · 2007 · Journal of neural transmission. Supplementum
73. Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and Presenilin
    Johannes Prox, Andrea Rittger, Paul Säftig · 2011 · Experimental Brain Research
74. Promotion of BACE1 mRNA Alternative Splicing Reduces Amyloid β-Peptide Production
    Mowrer, Karen R., Wolfe, Michael S. · 2008 · Journal of Biological Chemistry
75. Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease
    Charbel Moussa · 2017 · Expert Opinion on Investigational Drugs
76. Reversible Overexpression of Bace1-Cleaved Neuregulin-1 N-Terminal Fragment Induces Schizophrenia-Like Phenotypes in Mice
    Xiaoyang Luo, Wanxia He, Xiangyou Hu, Riqiang Yan · 2013 · Biological Psychiatry
77. Neurological dysfunctions associated with altered BACE 1‐dependent Neuregulin‐1 signaling
    Xiangyou Hu, Qingyuan Fan, Hailong Hou, Riqiang Yan · 2015 · Journal of Neurochemistry
78. A novel spinal neuron connection for heat sensation
    Hongsheng Wang, Wenbing Chen, Zhaoqi Dong, Guanglin Xing, Wanpeng Cui, Lingling Yao, Wen-Jun Zou, Heath L. Robinson, Yaoyao Bian, Zhipeng Liu et al. · 2022 · Neuron
79. BACE1 activity regulates cell surface contactin-2 levels
    Gautam, Vivek, D’Avanzo, Carla, Hebisch, Matthias, Kovacs, Dora M, Kim, Doo Yeon · 2014 · Molecular Neurodegeneration
80. Determination of the Proteolytic Cleavage Sites of the Amyloid Precursor-Like Protein 2 by the Proteases ADAM10, BACE1 and γ-Secretase
    Sebastian Hogl, Peer‐Hendrik Kuhn, Alessio Vittorio Colombo, Stefan F. Lichtenthaler · 2011 · PLoS ONE
81. Neural functions of bisecting GlcNAc
    Yasuhiko Kizuka, Naoyuki Taniguchi · 2018 · Glycoconjugate Journal
82. Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function
    Kaichuan Zhu, Finn Peters, Severin Filser, Jochen Wolfgang Herms · 2018 · Biological Psychiatry
83. Sensory Axon-Derived Neuregulin-1 Is Required for Axoglial Signaling and Normal Sensory Function But Not for Long-Term Axon Maintenance
    Florence R. Fricker, N. Zhu, Christoforos Tsantoulas, Bjarke Abrahamsen, Mohammed A. Nassar, Matthew Thakur, Alistair N. Garratt, Carmen Birchmeier, Stephen Brendan McMahon, JN Wood et al. · 2009 · Journal of Neuroscience
84. Modeling an Anti-Amyloid Combination Therapy for Alzheimer’s Disease
    Vivian W. Chow, Alena V. Savonenko, Tatiana Melnikova, Hyun‐Su Kim, Donald L. Price, Tong Li, Philip C. Wong · 2010 · Science Translational Medicine
85. Alzheimer's Therapeutics: Translation of Preclinical Science to Clinical Drug Development
    Alena V. Savonenko, Tatiana Melnikova, Andrew Hiatt, Tong Li, Paul F. Worley, Juan Carlos Troncoso, Phil C Wong, Don L Price · 2011 · Neuropsychopharmacology
86. Cyanobacterial peptides as a prototype for the design of potent β-secretase inhibitors and the development of selective chemical probes for other aspartic proteases.
    Yanxia Liu, Wei Zhang, Li Li, Lilibeth A. Salvador, Tiantian Chen, Wu-Yan Chen, K. Felsenstein, T. Ladd, Ashleigh R. Price, T. Golde et al. · 2012 · Journal of Medicinal Chemistry
87. Proteolytic Processing of Neuregulin 1 Type III by Three Intramembrane-cleaving Proteases
    Daniel Fleck, Matthias Voß, Ben Brankatschk, Camilla Giudici, Heike Hampel, Benjamin M. Schwenk, Dieter Edbauer, Akio Fukumori, Harald Steiner, Elisabeth Kremmer et al. · 2015 · Journal of Biological Chemistry
88. Alzheimer’s therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies
    Masuo Ohno · 2016 · Brain Research Bulletin
89. Proteolytic processing of Neuregulin-1
    Michael Willem · 2016 · Brain Research Bulletin
90. Therapeutic Potential of Multifunctional Tacrine Analogues
    Maja Przybyłowska, Szymon Kowalski, Krystyna Dzierzbicka, Iwona Inkielewicz‐Stępniak · 2018 · Current Neuropharmacology
91. Methylene Blue Modulates β-Secretase, Reverses Cerebral Amyloidosis, and Improves Cognition in Transgenic Mice
    Takashi Mori, Naoki Koyama, Tatsuya Segawa, Masahiro Maeda, Nobuhiro Maruyama, Noriaki Kinoshita, Huayan Hou, Jun Tan, Terrence Town · 2014 · Journal of Biological Chemistry
92. Inhibition of β-Secretase in Vivo via Antibody Binding to Unique Loops (D and F) of BACE1*
    Lujia Zhou, L. Chávez-Gutiérrez, Katrijn Bockstael, Ragna Sannerud, W. Annaert, P. May, E. Karran, B. de Strooper · 2011 · Journal of Biological Chemistry
93. Axonal regulation of Schwann cell ensheathment and myelination
    James L. Salzer · 2012 · Journal of the Peripheral Nervous System
94. Future Therapeutics in Alzheimer’s Disease: Development Status of BACE Inhibitors
    Genevieve M. Evin · 2016 · BioDrugs
95. Coumarins and Related Compounds from the Medicinal Plants of Africa
    Hervé Martial Poumale Poumale, Rebecca L. Hamm, Yanqing Zang, Yoshihito Shiono, Victor Kuete · 2013 · Elsevier eBooks
96. Rheb GTPase Regulates β-Secretase Levels and Amyloid β Generation
    Neelam Shahani, William Pryor, Supriya Swarnkar, Nikolai G. Kholodilov, Gopal Thinakaran, Robert E. Burke, Srinivasa Subramaniam · 2013 · Journal of Biological Chemistry
97. The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer’s disease
    Mariana G. Fronza, Diego A.C. Alves, Domenico Praticò, Lucielli Savegnago · 2023 · Ageing Research Reviews
98. Piperazine sulfonamide BACE1 inhibitors: Design, synthesis, and in vivo characterization
    Jared N. Cumming, Suresh Babu, Ying Huang, Carolyn DiIanni Carroll, Xia Chen, Leonard V. Favreau, William J. Greenlee, Tao Guo, Matthew E Kennedy, Reshma Kuvelkar et al. · 2010 · Bioorganic & Medicinal Chemistry Letters
99. Early Intervention in Alzheimer’s Disease: How Early is Early Enough?
    Dong‐Yu Fan, Yan-Jiang Wang · 2019 · Neuroscience Bulletin
100. Erbin Is Required for Myelination in Regenerated Axons after Injury
     Chuan Liang, Yanmei Tao, Chengyong Shen, Zui Tan, Wen‐Cheng Xiong, Lin Mei · 2012 · Journal of Neuroscience